and AS activity, as assessed by the Bath AS Disease Activity Index (BASDAI), were analysed. The number of peripheral blood CD4 + CD25 high CD127 low/-T reg cells in AS patients was found to be significantly lower than in healthy controls and was inversely correlated with serum IgA levels. There was no significant correlation between CD4 + CD25 high CD127 low/-T reg cell numbers and BASDAI scores. It is concluded that CD4 + CD25 high CD127 low/-T reg cells may play a role in the pathogenesis and activity of AS.
Introduction
Ankylosing spondylitis (AS) is a common rheumatic disorder affecting the spine, sacroiliac and peripheral joints, in which the infiltration of inflammatory CD4 + T-cells, CD8 + T-cells and macrophages may be particularly important to the development of structural lesions. 1 Regulatory T (T reg ) cells play a crucial role in maintaining selftolerance by suppressing autoreactive Tcells. 2 When this tolerance breaks down, as a result of impairment of T reg cells or increased proinflammatory stimuli, inflammation may occur. Abnormalities in T reg cells have been associated with several autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, myasthenia gravis, Kawasaki disease, autoimmune polyglandular syndrome and systemic lupus erythematosus. 3 Combined detection of the cell surface markers CD25 and CD127 has been proposed as a method for identification of T reg cells in human whole blood and as a T-cells and IgA in ankylosing spondylitis biomarker for human T reg cells in autoimmune diseases. 4, 5 Most of the common markers used to characterize T reg cells are not T reg specific; CD25, for example, is only an accurate marker of T reg cells when the CD25 high fraction is considered. 4, 5 Furthermore, the majority of CD4 + CD25 + Tcells, including CD4 + CD25 high T-cells, have low levels of CD127. 5 It was, therefore, thought that selecting specifically for CD4 + CD25 high CD127 low/-T reg cells may further increase the purity of the T reg cells.
The possibility that CD4 + CD25 high CD127 low/-T reg cells may play a role in the pathogenesis of AS has not been explored. The present study evaluated the CD4 + CD25 high CD127 low/-T reg cell phenotype in patients with new-onset, treatment-naïve AS compared with healthy control subjects, and examined the relationship of the number of CD4 + CD25 high CD127 low/-T reg cells with serum levels of immunoglobulin A (IgA) and AS disease activity. 6 Age-and gender-matched healthy volunteers, recruited from the general population of Dongyang, China, were used as a control group. AS patients who had received prior treatment with immunosuppressive agents or glucocorticoid drugs and those with other rheumatic diseases were excluded from the study. Healthy subjects with a history of therapy with glucocorticosteroids, or other drugs, that could have affected immune function were also excluded.
Patients and methods

STUDY POPULATION
All participants provided written informed consent prior to study enrolment. The study was approved by the Academic and Ethics Committee of Wenzhou Medical College Affiliated with Dongyang Hospital.
CLINICAL ASSESSMENTS
Information on the disease course was collected from patient records. Blood samples were drawn from patients and healthy volunteers on enrolment into the study after an overnight fast. Serum was isolated within 60 min of blood sample collection for immediate analysis. A 2-ml blood sample (with 3.8% sodium citrate) was used to measure erythrocyte sedimentation rate using the Westergren method. A 5 ml sample of blood was taken for the measurement of C-reactive protein (CRP) or IgA. After blood coagulation, the blood was centrifuged at 400 g for 5 min at 4°C to collect serum. CRP was measured by nephelometry (Dade Behring, Behring, Germany) and IgA was measured using standard immunonephelometry and preparations (Dade Behring, Deerfield, IL, USA).
The disease activity of AS was measured using the Bath AS Disease Activity Index (BASDAI). 7 This is a self-reporting, six-item questionnaire where patients rate each of the five major symptoms of AS: fatigue, spinal pain, peripheral joint pain/swelling, areas of localized tenderness (also called enthesitis, or inflammation of tendons and ligaments), and severity of morning stiffness. This was done over the course of a week using a 10-cm visual analogue scale (VAS) from no symptom (0 cm) to very severe symptom (10 cm). The final (sixth) question asks the patient to quantify the duration of morning stiffness over the past week on a scale ranging from 0 to 2+ h. The T-cells and IgA in ankylosing spondylitis combined mean score for questions 5 and 6 is calculated and added to the scores of the other four questions; lower scores indicate less active disease.
FLOW CYTOMETRY ANALYSIS
The number of CD4 + CD25 high CD127 low/-T reg cells in the peripheral blood of AS patients and healthy volunteers was assessed by fluorescence-activated cell sorting (FACS) flow cytometry using the following antibodies to cell surface antigens: fluorescein isothiocyanate-conjugated antihuman CD4 (clone RPA-T4); phycoerythrin (PE)-cyano dye Cy5 tandem conjugated antihuman CD25 (clone M-A251); PEconjugated anti-CD127 (clone hil-7R-M21); or relevant isotype-and fluorochromematched control antibodies (all from BD Biosciences, San José, CA, USA). Briefly, 2 µl of each of the three antibodies (or isotype control antibodies) were added together to 50 µl of fresh whole blood and incubated for 15 min at room temperature. Then, 2 ml FACS Lyse (BD Biosciences) was added to each sample for 10 min at room temperature to lyse the red blood cells. The tubes were filled to the top with calcium-and magnesiumfree 0.01 M phosphate-buffered saline, pH 7.4, containing 2% fetal bovine serum and centrifuged at 400 g for 5 min at 4°C to collect the cells. Flow cytometry analysis was performed using a FACSCalibur TM analyser (BD Biosciences) with WinMDI version 2.9 free FACS analysis software. The CD4 + CD25 high CD127 low/-T reg cells were counted as a percentage of the total CD4 + Tcell pool after gating the CD4 + CD25 high cells that were also CD127 low/-. The top 2% of CD25 + cells in each gate was defined as the CD25 high population.
STATISTICAL ANALYSES
Statistical analyses were carried out using the SPSS ® statistical package, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . An independent-sample t-test was used to compare baseline clinical characteristics and CD4 + CD25 high CD127 low/-T reg cell numbers between the two groups. Spearman's rank correlation coefficient was used to analyse the relationship between the number of CD4 + CD25 high CD127 low/-T reg cells and patients' BASDAI scores or serum IgA levels. A value of P < 0.05 was considered to be statistically significant.
Results
In total, 14 patients with new-onset AS (one female, 13 males) and 18 healthy control subjects (one female, 17 males) were included in the study. There were no statistically significant between-group differences in terms of baseline clinical characteristics with the exception of serum IgA levels, which were significantly higher in the AS patient group compared with the control group (mean ± SD 4.3 ± 1.0 g/l versus 1.9 ± 0.6 g/l, P < 0.001; Table 1 ).
The 14 AS patients had significantly lower levels of CD4 + CD25 high CD127 low/-T reg cells compared with the 18 normal controls (mean ± SD 0.57% ± 0.29% versus 1.65% ± 0.75%, P < 0.001, Fig. 1 ).
There was a significant inverse relationship between the number of CD4 + CD25 high CD127 low/--T reg cells and serum IgA levels in patients with AS (r = −0.738, P = 0.003; Fig. 2 ). There was no significant relationship between the number of CD4 + CD25 high CD127 low/-T reg cells and BASDAI scores (r = 0.307; data not shown).
Discussion
Regulatory T-cells actively suppress both physiological and pathological immune responses and are, therefore, important in establishing self-tolerance and in T-cells and IgA in ankylosing spondylitis maintaining immune homeostasis. 8 One study reported aberrant numbers and/or function of T reg cells in various human autoimmune diseases, 9 however it has not been possible to compare results in the literature for differences in numbers and functionality of T reg cells in different inflammatory conditions. This may be due, at least in part, to the difficulty in accurately distinguishing T reg cells from activated conventional CD25 + T-cells, particularly in humans. 10 One significant advance in the study of T reg cells has been the discovery of the transcription factor FoxP3 as a major T reg cell marker and regulator of T reg cell development and function. 11 The role of FoxP3 as a key marker for T reg cells in humans remains controversial as FoxP3 is also upregulated in some activated peripheral CD4 + T-cells, 12 and an increase in FoxP3 does not always confer a T reg cell phenotype. 13 It has been shown that staining for both CD127 and CD25 can be used to discriminate T reg cells from activated Tcells. 4, 5 Potent immuno suppressive activity has been shown by CD4 + CD25 + CD127 low/-T reg cells, 5 suggesting that CD127 may be an excellent marker of T reg cells in human peripheral blood. Although previous studies have used the CD4 + CD25 + CD127 low/-T reg cell subset, 4,5 the present study and that of Venigalla et al. 14 used CD4 + CD25 high CD127 low/-T reg cells to increase further the purity of the T reg cells.
Only patients with new-onset AS who had not received previous treatment for their condition were included in the present study in order to exclude any influence of treatment on T reg cell numbers. AS occurs most frequently in men, 15 therefore, the bias toward male patients in the present study was unlikely to have affected the results.
Although it is difficult to show definitively that a reduced level of CD4 + CD25 high CD127 low/-T reg cells plays a role in the chronic inflammatory arthritis of AS, the fact that CD4 + CD25 high CD127 low/-T reg cells were decreased in patients with AS compared with normal controls suggests that they may play an important role in the pathogenesis of AS.
Serum IgA levels were significantly higher in patients with new-onset AS compared with the control group in the present study. Shodjai-Moradi et al. 16 found that IgA levels were significantly elevated in patients with active AS compared with patients with inactive AS or rheumatoid arthritis, or with healthy controls. Other studies have also reported elevated IgA levels in patients with AS and compared with patients with rheumatoid arthritis. 17 -19 A biochemical study has demonstrated an association between increased AS disease activity and increased serum IgA levels. 20 The increase in IgA levels is an indicator of an increase in the enterobacterial antigenic stimulation • Received for publication 18 May 2011 • Accepted subject to revision 23 May 2011 • Revised accepted 1 September 2011 Copyright © 2011 Field House Publishing LLP that occurs in the gastrointestinal tract during the active phase of the disease. 21 The present study showed an inverse correlation between CD4 + CD25 high CD127 low/-T reg cells and serum IgA levels in new-onset AS, suggesting that decreased numbers of CD4 + CD25 high CD127 low/-T reg cells may be associated with AS disease activity. There was, however, no significant correlation between CD4 + CD25 high CD127 low/-T reg cells and the BASDAI score, a conventional marker of AS disease activity.
In conclusion, the present study demonstrated decreased numbers of CD4 + CD25 high CD127 low/-T reg cells in peripheral blood of patients with new-onset, treatment-naïve AS. This decrease in the numbers of CD4 + CD25 high CD127 low/-T reg cells may play a role in the proinflammatory milieu in AS. Further investigation is needed to evaluate the exact pathogenic mechanisms that account for these modified numbers of T reg cells in AS patients.
